You are here

Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13®

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Gabinet Lekarski
Debica, , 39-200 Poland
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pneumococcal Vaccines
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
56-98 days
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Aged 2 months (56 to 98 days) at time of enrollment.

- Healthy infant as determined by medical history, physical examination, and judgment of
the investigator.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Previous vaccination with licensed or investigational pneumococcal, diphtheria,
tetanus, pertussis, polio, or Hib conjugate vaccines.

- A previous anaphylactic reaction to any vaccine or vaccine-related component.

- Allergy or contraindication to paracetamol or ibuprofen administration.

- Contraindication to vaccination with pneumococcal conjugate, diphtheria, tetanus,
pertussis, polio, Hib, or HBV vaccines.

NCT01392378
Pfizer
Completed
Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13®

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now